Analyst Price Targets — SRTA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 17, 2025 12:40 pm | — | Lake Street | $7.25 | $5.20 | TheFly | Strata Critical Medical price target raised to $7.25 from $6.50 at Lake Street |
Latest News for SRTA
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Will Heyburn, Strata's Co-Chief Executive…
$30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditions Owned aircraft excluded from collateral package and remain unencumbered NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), a leading provider of logistics and medical services in the organ transplant…
Strata Critical Medical, Inc. is refocused on organ transplant logistics after divesting its air passenger business, positioning for higher-margin, long-term growth. SRTA's acquisition of Keystone Perfusion fills a key service gap, boosting market share to 13% and enabling full-stack, technology-agnostic offerings in organ preservation. Keystone's strong FCF conversion (80%) and rapid revenue growth (45% YoY) are…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SRTA.
U.S. House Trading
No House trades found for SRTA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.